August 31, 2016 1:22 PM ET

Electronic Equipment, Instruments and Components

Company Overview of BiOptix Inc.

Company Overview

BiOptix Inc., an analytical instrumentation company, develops an array-based bio molecule detection systems and molecular interaction analysis instruments. The company’s products pipeline includes cell array biodetector systems, and biochip and optical cartridges; and pre-production small footprint and single cell biodetector systems. Its products are used to detect various molecules and micro organisms, including micro RNA, nucleic acids, proteins and antibodies, bacteria, viruses, carbohydrates, lipids, and low molecular weight drugs. The company serves clinical biomarkers and diagnostics, personalized medicine, infectious disease, drug discovery, biopharma and low molecular drug developme...

1775 38th Street

Suite A

Boulder, CO 80301

United States

Founded in 2003

Phone:

303-545-5550

Fax:

303-545-5551

Key Executives for BiOptix Inc.

Chief Executive Officer, President, and Member of Board of Directors
Co-Founder and Director of Research and Development
Chief Financial Officer
Vice President of Sales
Vice President of Chemistry & Biochemistry
Compensation as of Fiscal Year 2016.

BiOptix Inc. Key Developments

BiOptix Announces Partnership with XTAL BioStructures

BiOptix announced XTAL BioStructures Inc. is adding the BiOptix 404pi to its suite of biophysical tools. XTAL BioStructures is a contract research organization that provides drug discovery and intellectual property development services to the pharmaceutical and biotechnology industries, including high quality protein production, biophysical characterization, X-ray crystallography and with a focus on affinity-based screening techniques. XTAL is now able to offer customers access to BiOptix’s patented enhanced surface plasmon resonance (e-SPR) technology, which delivers high sensitivity (100 Da) and higher throughput by combining proprietary technology with an advanced, multi-injector fluidics system.

BiOptix Announces Simulject™ Application

BiOptix announced their Simulject Application, a tool which allows researchers to inject two different concentrations of an analyte simultaneously on a BiOptix 404pi without the need for regeneration. The Simulject Application is enabled by the unique flow cell architecture within the biosensor. Two independent flow paths, each containing a reference and experimental flow cell, allow two different concentrations of analyte to be injected simultaneously, resulting in the kinetics and KD for an interaction in one injection cycle. The application is critical for molecular systems in which surface regeneration is challenging or impossible to find, thus saving researchers time and money. This technology adds another key feature to the BiOptix 404pi, which utilizes patented phase-based SPR technology, delivering high sensitivity (100 Da) and higher throughput without the high price tag. The 404pi utilizes 4 parallel channels allowing simultaneous characterization of 4 samples, and uses 96 well plates. Additional Features of the BiOptix 404pi include: phase-based SPR for high sensitivity; 4 injector /4 flow cell design for higher throughput; advanced automated fluidic system for fast kinetic measurements; multiple surface chemistries; compatible with industry standard Scrubber 2 software; and cost-effective and simple to operate.

BiOptix Appoints Scott Klakamp as Vice President of Chemistry and Biochemistry

BiOptix announced the appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry. Scott joins the company after previous scientific leadership positions at Takeda Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course of his nearly 20 year career in therapeutics discovery and development.

Similar Private Companies By Industry

Company Name Region
#1 Network, Inc. United States
10x Communications, Inc. United States
1450 Inc. United States
1st Choice Security Solutions, Inc. United States
20th Century Lites, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
November 13, 2015
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BiOptix Inc., please visit www.bioptix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.